• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡维地洛和褪黑素对神经母细胞瘤 3-硝基丙酸诱导的神经毒性的神经保护作用。

Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.

机构信息

Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba, 14004 Córdoba, Spain.

出版信息

J Physiol Biochem. 2009 Sep;65(3):291-6. doi: 10.1007/BF03180581.

DOI:10.1007/BF03180581
PMID:20119823
Abstract

In neurodegenerative diseases, progressive oxidative stress is a major event that precedes neuronal death. Oxidative stress is characterized by an imbalance between oxidants and antioxidants. This imbalance induced oxidative molecular and cell damage, reducing cellular viability. 3-Nitropropionic acid (3NP) causes oxidative stress and other molecular and cellular changes similar to those observed in neurons of patients with Huntington's disease. Since carvedilol and melatonin act as free-radical scavengers, this study examined the effect of carvedilol (10(-5) M) and melatonin (10(-5) M) on oxidative and cell damage induced by 3NP in N1E-115 neuroblastoma cells. Carvedilol and melatonin prevented the increases in lipid peroxidation and total LDH activity, as well as the depletion of reduced glutathione (GSH) and the reduction of antioxidative enzymes activities in N1E-115 cells incubated with 100 mM 3NP. All these carvedilol and melatonin effects were more intense when the drugs were added before rather than after inducing the damage by 3NP. These results also provided evidence supporting the hypothesis that carvedilol and melatonin can be useful for treating neurodegenerative diseases, such as Huntington's disease.

摘要

在神经退行性疾病中,进行性氧化应激是导致神经元死亡的主要事件。氧化应激的特征是氧化剂和抗氧化剂之间的不平衡。这种不平衡引起氧化的分子和细胞损伤,降低细胞活力。3-硝基丙酸(3NP)引起的氧化应激和其他分子和细胞变化类似于亨廷顿病患者神经元中观察到的变化。由于卡维地洛和褪黑素作为自由基清除剂,本研究探讨了卡维地洛(10(-5)M)和褪黑素(10(-5)M)对 3NP 在 N1E-115 神经母细胞瘤细胞中诱导的氧化和细胞损伤的影响。卡维地洛和褪黑素可防止脂质过氧化和总 LDH 活性增加,以及降低谷胱甘肽(GSH)水平和抗氧化酶活性降低,在 100mM 3NP 孵育的 N1E-115 细胞中。当药物在 3NP 诱导损伤之前而不是之后添加时,卡维地洛和褪黑素的所有这些作用都更加明显。这些结果也为卡维地洛和褪黑素可用于治疗亨廷顿病等神经退行性疾病的假说提供了证据。

相似文献

1
Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.卡维地洛和褪黑素对神经母细胞瘤 3-硝基丙酸诱导的神经毒性的神经保护作用。
J Physiol Biochem. 2009 Sep;65(3):291-6. doi: 10.1007/BF03180581.
2
Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells.卡维地洛对冈田酸诱导的N1E-115细胞氧化应激的保护作用。
Pharmacol Res. 2006 Sep;54(3):241-6. doi: 10.1016/j.phrs.2006.05.004. Epub 2006 Jun 6.
3
Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.卡维地洛长期预处理可预防3-硝基丙酸诱导的大鼠行为改变和氧化应激。
Pharmacol Rep. 2008 Sep-Oct;60(5):706-15.
4
Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.卡维地洛,一种新型抗高血压药物,可预防脂质过氧化和内皮细胞的氧化损伤。
Hypertension. 1993 Dec;22(6):922-8. doi: 10.1161/01.hyp.22.6.922.
5
Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome.天然和合成抗氧化剂在慢性疲劳综合征小鼠模型中的作用。
J Med Food. 2002 Winter;5(4):211-20. doi: 10.1089/109662002763003366.
6
Coronary artery disease and antioxidants--is there a role for carvedilol?冠状动脉疾病与抗氧化剂——卡维地洛能发挥作用吗?
J Clin Pharm Ther. 1997 Feb;22(1):3-5. doi: 10.1046/j.1365-2710.1997.8275082.x.
7
Carvedilol protects against glomerulosclerosis in rat remnant kidney without general changes in antioxidant enzyme status. A comparative study of two beta-blocking drugs, carvedilol and propanolol.卡维地洛可预防大鼠残余肾的肾小球硬化,且对抗氧化酶状态无总体影响。卡维地洛与普萘洛尔这两种β受体阻滞剂的比较研究。
Nephron. 1997;77(3):319-24. doi: 10.1159/000190295.
8
Role of antioxidants in chronic fatigue syndrome in mice.抗氧化剂在小鼠慢性疲劳综合征中的作用。
Indian J Exp Biol. 2002 Nov;40(11):1240-4.
9
Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model.橄榄油可减少 3-硝基丙酸诱导的似亨廷顿病大鼠模型中的氧化损伤。
Nutr Neurosci. 2011 May;14(3):106-11. doi: 10.1179/1476830511Y.0000000005.
10
Melatonin prevents cytoskeletal alterations and oxidative stress induced by okadaic acid in N1E-115 cells.褪黑素可预防冈田酸诱导的N1E-115细胞的细胞骨架改变和氧化应激。
Exp Neurol. 2003 Jul;182(1):151-9. doi: 10.1016/s0014-4886(03)00085-2.

引用本文的文献

1
Melatonin-A Powerful Antioxidant in Neurodegenerative Diseases.褪黑素——神经退行性疾病中的一种强大抗氧化剂。
Antioxidants (Basel). 2025 Jul 3;14(7):819. doi: 10.3390/antiox14070819.
2
The therapeutic potential of (R)-carvedilol in Huntington's disease through enhancement of autophagy-lysosomal pathway via GSK-3β inhibition.(R)-卡维地洛通过抑制GSK-3β增强自噬-溶酶体途径对亨廷顿病的治疗潜力。
Neurotherapeutics. 2025 Apr;22(3):e00557. doi: 10.1016/j.neurot.2025.e00557. Epub 2025 Feb 25.
3
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.

本文引用的文献

1
[Model of Huntington's disease induced with 3-nitropropionic acid].[3-硝基丙酸诱导的亨廷顿舞蹈病模型]
Rev Neurol. 2009;48(8):430-4.
2
Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats.卡维地洛长期预处理可预防3-硝基丙酸诱导的大鼠行为改变和氧化应激。
Pharmacol Rep. 2008 Sep-Oct;60(5):706-15.
3
Attenuation of cardiac mitochondrial dysfunction by melatonin in septic mice.褪黑素对脓毒症小鼠心脏线粒体功能障碍的减轻作用
亨廷顿舞蹈症治疗中生物活性化合物和半合成分子的临床研究及未来前景
Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12.
4
Carvedilol attenuates acrylamide-induced brain damage through inhibition of oxidative, inflammatory, and apoptotic mediators.卡维地洛通过抑制氧化、炎症和凋亡介质减轻丙烯酰胺诱导的脑损伤。
Iran J Basic Med Sci. 2022 Jan;25(1):60-67. doi: 10.22038/IJBMS.2021.58808.13063.
5
Melatonin as a mitochondrial protector in neurodegenerative diseases.褪黑素作为神经退行性疾病中的线粒体保护剂。
Cell Mol Life Sci. 2017 Nov;74(21):3999-4014. doi: 10.1007/s00018-017-2614-x. Epub 2017 Aug 8.
6
Comparison of the Effects of 13-cis Retinoic Acid and Melatonin on the Viabilities of SH-SY5Y Neuroblastoma Cell Line.13-顺式维甲酸与褪黑素对SH-SY5Y神经母细胞瘤细胞系活力影响的比较
J Korean Neurosurg Soc. 2015 Mar;57(3):147-51. doi: 10.3340/jkns.2015.57.3.147. Epub 2015 Mar 20.
7
A mitochondrial basis for Huntington's disease: therapeutic prospects.亨廷顿病的线粒体基础:治疗前景。
Mol Cell Biochem. 2014 Apr;389(1-2):277-91. doi: 10.1007/s11010-013-1951-9. Epub 2013 Dec 29.
8
Type 2 transglutaminase in Huntington's disease: a double-edged sword with clinical potential.亨廷顿病中的 2 型转谷氨酰胺酶:具有临床潜力的双刃剑。
J Intern Med. 2010 Nov;268(5):419-31. doi: 10.1111/j.1365-2796.2010.02275.x.
FEBS J. 2007 Apr;274(8):2135-47. doi: 10.1111/j.1742-4658.2007.05755.x. Epub 2007 Mar 20.
4
Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells.卡维地洛对冈田酸诱导的N1E-115细胞氧化应激的保护作用。
Pharmacol Res. 2006 Sep;54(3):241-6. doi: 10.1016/j.phrs.2006.05.004. Epub 2006 Jun 6.
5
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.亨廷顿舞蹈症或慢性脑损伤患者的血液5-羟色胺、5-羟吲哚乙酸及褪黑素水平
J Neurochem. 2006 May;97(4):1078-88. doi: 10.1111/j.1471-4159.2006.03807.x. Epub 2006 Mar 29.
6
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.3-硝基丙酸:一种线粒体毒素,用于揭示亨廷顿舞蹈病纹状体变性潜在的生理病理机制。
J Neurochem. 2005 Dec;95(6):1521-40. doi: 10.1111/j.1471-4159.2005.03515.x. Epub 2005 Nov 21.
7
Oxidative-nitrosative stress in hypertension.高血压中的氧化-亚硝化应激
Curr Vasc Pharmacol. 2005 Jul;3(3):231-46. doi: 10.2174/1570161054368643.
8
Effect of nicotine on 3-nitropropionic acid-induced oxidative stress in synaptosomes.尼古丁对3-硝基丙酸诱导的突触体氧化应激的影响。
Eur J Pharmacol. 2004 Nov 19;504(3):169-75. doi: 10.1016/j.ejphar.2004.09.061.
9
Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.褪黑素对亨廷顿舞蹈病动物模型中3-硝基丙酸诱导的突触体氧化应激的保护作用。
J Pineal Res. 2004 Nov;37(4):252-6. doi: 10.1111/j.1600-079X.2004.00163.x.
10
Pharmacology of carvedilol.卡维地洛的药理学
Am J Cardiol. 2004 May 6;93(9A):3B-6B. doi: 10.1016/j.amjcard.2004.01.003.